Integrating clinical and commercial evidence planning can create efficiencies and produce data that will promote both initial commercial success and sustained viability. But integration is no easy feat. Companies with a strategic mindset that integrates clinical and commercial teams in early engagements with regulators and HTA agencies will benefit; companies that pass up the opportunity, or come insufficiently prepared, will likely struggle to succeed.
Read this article to find out how engaging with local affiliates from day one is essential to understand an...
Most Recent Flipbooks
A lay summary for patients participating in clinical trials
Parexel expert Michelle Pietzak, MD reviews current findings and offers practical recommendations for gastrointestinal symptoms of COVID-19 and considerations for clinical trials.
In this article, experts from the Parexel Pediatric Collaborative Group review current findings and consider how sponsors can adapt their studies to changing conditions during COVID19.
This lay summary discusses what the guidance means for anyone in the USA who may be involved in or associated with a clinical trial.
In this article, Dr. Lazar Mandinov, Sr. Medical Director at Parexel, provides practical guidance for conducting CV clinical trials related to COVID-19.
Updated every day, in a single source
If regulatory and payer landscapes are so different, then why bring the two worlds together?
Parexel offers a complimentary, educational workshop custom built to your evidence and market access needs.